Literature DB >> 28290735

Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3.

Wolfgang G Kreyling1,2, Uwe Holzwarth3, Nadine Haberl1, Ján Kozempel3, Alexander Wenk1, Stephanie Hirn1, Carsten Schleh1, Martin Schäffler1, Jens Lipka1, Manuela Semmler-Behnke1, Neil Gibson3.   

Abstract

The biokinetics of a size-selected fraction (70 nm median size) of commercially available and 48V-radiolabeled [48V]TiO2 nanoparticles has been investigated in healthy adult female Wistar-Kyoto rats at retention time-points of 1 h, 4 h, 24 h, 7 d and 28 d after intratracheal instillation of a single dose of an aqueous [48V]TiO2-nanoparticle suspension. A completely balanced quantitative biodistribution in all organs and tissues was obtained by applying typical [48V]TiO2-nanoparticle doses in the range of 40-240 μg·kg-1 bodyweight and making use of the high sensitivity of the radiotracer technique. The [48V]TiO2-nanoparticle content was corrected for residual blood retained in organs and tissues after exsanguination and for 48V-ions not bound to TiO2-nanoparticles. About 4% of the initial peripheral lung dose passed through the air-blood-barrier after 1 h and were retained mainly in the carcass (4%); 0.3% after 28 d. Highest organ fractions of [48V]TiO2-nanoparticles present in liver and kidneys remained constant (0.03%). [48V]TiO2-nanoparticles which entered across the gut epithelium following fast and long-term clearance from the lungs via larynx increased from 5 to 20% of all translocated/absorbed [48V]TiO2-nanoparticles. This contribution may account for 1/5 of the nanoparticle retention in some organs. After normalizing the fractions of retained [48V]TiO2-nanoparticles to the fraction that reached systemic circulation, the biodistribution was compared with the biodistributions determined after IV-injection (Part 1) and gavage (GAV) (Part 2). The biokinetics patterns after IT-instillation and GAV were similar but both were distinctly different from the pattern after intravenous injection disproving the latter to be a suitable surrogate of the former applications. Considering that chronic occupational inhalation of relatively biopersistent TiO2-particles (including nanoparticles) and accumulation in secondary organs may pose long-term health risks, this issue should be scrutinized more comprehensively.

Entities:  

Keywords:  Size-selected, radiolabeled titanium dioxide nanoparticles; accumulation in secondary organs and tissues; different biokinetics patterns after intratracheal instillation and gavage versus intravenous injection; gut-absorption of swallowed nanoparticles; intratracheal instillation; nanoparticle translocation across the air-blood-barrier

Mesh:

Substances:

Year:  2017        PMID: 28290735     DOI: 10.1080/17435390.2017.1306894

Source DB:  PubMed          Journal:  Nanotoxicology        ISSN: 1743-5390            Impact factor:   5.913


  22 in total

1.  Probabilistic risk assessment of gold nanoparticles after intravenous administration by integrating in vitro and in vivo toxicity with physiologically based pharmacokinetic modeling.

Authors:  Yi-Hsien Cheng; Jim E Riviere; Nancy A Monteiro-Riviere; Zhoumeng Lin
Journal:  Nanotoxicology       Date:  2018-04-14       Impact factor: 5.913

2.  Evaluation of immunologic and intestinal effects in rats administered an E 171-containing diet, a food grade titanium dioxide (TiO2).

Authors:  Lance K Blevins; Robert B Crawford; Anthony Bach; Michael D Rizzo; Jiajun Zhou; Joseph E Henriquez; D M Isha Olive Khan; Sera Sermet; Lora L Arnold; Karen L Pennington; Nathalia P Souza; Samuel M Cohen; Norbert E Kaminski
Journal:  Food Chem Toxicol       Date:  2019-08-29       Impact factor: 6.023

3.  Short-term exposure to urban PM2.5 particles induces histopathological and inflammatory changes in the rat small intestine.

Authors:  Lena Ohlsson; Christina Isaxon; Sebastian Wrighton; Wissal El Ouahidi; Lisa Fornell; Lena Uller; Saema Ansar; Ulrikke Voss
Journal:  Physiol Rep       Date:  2022-04

4.  Specific Surface Modifications of Silica Nanoparticles Diminish Inflammasome Activation and In Vivo Expression of Selected Inflammatory Genes.

Authors:  Viviana Marzaioli; Christina J Groß; Ingrid Weichenmeier; Carsten B Schmidt-Weber; Jan Gutermuth; Olaf Groß; Francesca Alessandrini
Journal:  Nanomaterials (Basel)       Date:  2017-10-30       Impact factor: 5.076

5.  Primary genotoxicity in the liver following pulmonary exposure to carbon black nanoparticles in mice.

Authors:  Justyna Modrzynska; Trine Berthing; Gitte Ravn-Haren; Nicklas Raun Jacobsen; Ingrid Konow Weydahl; Katrin Loeschner; Alicja Mortensen; Anne Thoustrup Saber; Ulla Vogel
Journal:  Part Fibre Toxicol       Date:  2018-01-03       Impact factor: 9.400

6.  Combined Subchronic Toxicity of Aluminum (III), Titanium (IV) and Silicon (IV) Oxide Nanoparticles and Its Alleviation with a Complex of Bioprotectors.

Authors:  Ilzira A Minigalieva; Boris A Katsnelson; Larisa I Privalova; Marina P Sutunkova; Vladimir B Gurvich; Vladimir Y Shur; Ekaterina V Shishkina; Irene E Valamina; Oleg H Makeyev; Vladimir G Panov; Anatoly N Varaksin; Tatiana V Bushueva; Renata R Sakhautdinova; Svetlana V Klinova; Svetlana N Solovyeva; Ekaterina Y Meshtcheryakova
Journal:  Int J Mol Sci       Date:  2018-03-13       Impact factor: 5.923

7.  Nanosized titanium dioxide-induced premature ovarian failure is associated with abnormalities in serum parameters in female mice.

Authors:  Fashui Hong; Ling Wang
Journal:  Int J Nanomedicine       Date:  2018-04-27

8.  Suppression of testosterone production by nanoparticulate TiO2 is associated with ERK1/2-PKA-PKC signaling pathways in rat primary cultured Leydig cells.

Authors:  Lingjuan Li; Xu Mu; Lingqun Ye; Yuguan Ze; Fashui Hong
Journal:  Int J Nanomedicine       Date:  2018-09-28

9.  Detection of titanium particles in human liver and spleen and possible health implications.

Authors:  M B Heringa; R J B Peters; R L A W Bleys; M K van der Lee; P C Tromp; P C E van Kesteren; J C H van Eijkeren; A K Undas; A G Oomen; H Bouwmeester
Journal:  Part Fibre Toxicol       Date:  2018-04-11       Impact factor: 9.400

Review 10.  Hazard and risk assessment strategies for nanoparticle exposures: how far have we come in the past 10 years?

Authors:  David B Warheit
Journal:  F1000Res       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.